Clinical Research Directory
Browse clinical research sites, groups, and studies.
Adjunctive Bright Light Therapy for Opioid Use Disorder
Sponsor: Arizona State University
Summary
Investigators propose to conduct a pilot single-blind, parallel arm, randomized placebo-controlled trial evaluating the feasibility, acceptability, and preliminary efficacy of bright light therapy on reward system functioning among patients undergoing medication-assisted treatment for opioid use disorder.
Official title: Adjunctive Wearable Bright Light Therapy for Patients With Opioid Use Disorder: A Pilot Study
Key Details
Gender
All
Age Range
18 Years - 65 Years
Study Type
INTERVENTIONAL
Enrollment
23
Start Date
2022-10-23
Completion Date
2026-05-31
Last Updated
2025-08-22
Healthy Volunteers
No
Conditions
Interventions
Wearable bright light therapy device
Light treatment glasses (Re-timer®) will be used to deliver bright light therapy. This device is available commercially and allows participants to freely move around while receiving light from LEDs positioned below the eyes. Re-timer® can be worn over glasses and does not interfere with vision, reading, or computer work.
Wearable placebo light therapy device
The placebo Re-timer® emits light intensity to a level that will not impact sleep and circadian timing and appears identical to the original Re-timer®.
Locations (1)
Arizona State University
Phoenix, Arizona, United States